Genetic alterations in the transcriptional repressor ETV6 are associated with hematological malignancies. Notably, the t(12;21) translocation leading to an ETV6-AML1 fusion gene is the most common genetic alteration found in childhood acute lymphoblastic leukemia. Moreover, most of these patients also lack ETV6 expression, suggesting a tumor suppressor function. To gain insights on ETV6 DNA-binding specificity and genome wide transcriptional regulation capacities, we performed chromatin immunoprecipitation experiments coupled to deep sequencing in a t(12;21)-positive pre-B leukemic cell line. This strategy led to the identification of ETV6-bound regions that were further associated to gene expression. ETV6 binding is mostly cell type-specific as only few regions are shared with other blood cell subtypes. Peaks localization and motif enrichment analyses revealed that this unique binding profile could be associated with the ETV6-AML1 fusion protein specific to the t(12;21) background. This study underscores the complexity of ETV6 binding and uncovers ETV6 transcriptional network in pre-B leukemia cells bearing the recurrent t(12;21) translocation.
Western blotting. 20 μg of nuclear protein extracts were diluted in Laemmli buffer and migrated on SDS-denaturating 10% polyacrylamide gels. Transfer on polyvinylidene difluoride membranes was performed at 4 °C overnight. Membranes were blocked in Blotto A solution (1X TBS, 5% milk and 0.05% Tween-20) prior to immunoblotting using the primary antibodies against ETV6 (1:1000; ab54705; Abcam) or GAPDH (1:1000; sc-31915; Santa Cruz) and HRP-coupled secondary antibodies anti-mouse (1:5000; sc-358914; Santa Cruz) and anti-goat (1:5000; sc-2961; Santa Cruz) IgG, respectively. Membranes were then assayed by enhanced chemiluminescence detection with Western Lightning Plus-ECL (PerkinElmer) according to the manufacturer protocol.
Chromatin immunoprecipitation. Chromatin immunoprecipitation (ChIP) has been performed as previously described 32 . Briefly, cross-linked chromatin isolated from 1.0 × 10 7 transduced Reh cells was used for immunoprecipitation with anti-HA magnetic beads (Thermo Fisher Scientific). DNA-protein complexes were eluted from the beads by competition with HA peptides prior to reverse-crosslinking and standard purification using phenol/chloroform/isoamyl alcohol (Sigma). The purified ChIP DNA was processed through TruSeq ChIP Sample Preparation Kit (Illumina) according to the manufacturer protocol. As positive control, a fraction of the amplified ChIP material was used to assess the ETV6 binding enrichment at the CLIC5A promoter 32 by quantitative PCR (qPCR) using primers listed in Supplementary Table S1 . Libraries were sequenced on the HiSeq 2500 system (Illumina) in paired-end mode (2 × 100 bp).
ChIP-seq data analysis. Raw reads were aligned on the Hg19 reference genome using bowtie v2.2.3 33 and filtered using a mapping quality threshold of 20. Reads were merged for both ETV6 and ETV6-HA populations (n = 3). Peaks were called in the ETV6-HA condition over the background obtained in the ETV6 condition (negative IP control) using MACS v2.1.1.20160309 34 with a q-value threshold of 0.1. Peaks overlapping blacklisted regions (ENCODE's EncodeDacMapabilityConsensus 35 , svelter's exclude file 36 and canva's filter file 37 ) or having a fold enrichment above 50 were discarded. Peaks were associated to ensembl genes using the closest gene transcription start site (TSS) annotations from HOMER and genomic coordinates from bedops' closest-features v2.4.19 38 . To define the minimal peak fold enrichment threshold (≥4.5), a Fisher's exact test p-value was calculated for the overlaps between ETV6 peaks and ETV6-modulated genes 32 against the proportion of ETV6 peaks in the complete ensembl genes repertoire. Genomic annotations of peaks and motif enrichment analyses were performed using HOMER v4.8 39 .
ETV6 ChIP-seq data in GM12878 and K562 cells are publically available as part of the ENCODE project. GM12878:https://www.encodeproject.org/files/ENCFF272DJU/@@download/ENCFF272DJU.bed.gz K562:https://www.encodeproject.org/files/ENCFF514SLV/@@download/ENCFF514SLV.bed.gz ETV6 peaks in GM12878 and K562 cells were thus obtained directly from the ENCODE platform as conservative IDR bed files (narrowPeak). The intersection of ETV6 peaks between cell types was obtained using pybedtools v.0.7.7 venn_mpl with default parameters 40 .
Chromatin state data of GM12878 cells were obtained from the NIH Roadmap Epigenomics Project Portal (E116, 15 coreMarks) 41 .
Results

Identification of genome wide ETV6-bound regions.
To determine the genomic regions bound by ETV6, we expressed ETV6 and HA-tagged ETV6 in 3 biological replicates of Reh pre-B leukemic cells ( Fig. 1A ). Of note, Reh cells lack endogenous wild-type ETV6 expression as a result of a t(12;21) translocation and a 12p13 locus deletion. These cells were then used for ChIP experiments using the HA epitope as a bait. We confirmed ETV6 binding to the CLIC5A promoter region, a validated ETV6 target gene 32 , in the 3 replicates, both by qRT-PCR ( Fig. 1B ) and high throughput sequencing (Fig. 1C ), indicating that our ChIP-seq data are suitable for the identification of ETV6-bound regions. Note that the mapping and the peak calling procedures were performed individually for each sample to confirm the reproducibility of the biological replicates ( Supplementary Fig S1) . To retrieve the maximum of significant and robust ETV6 peaks, the reads from the replicates were pooled.
The number of ETV6 peaks called varies markedly with the fold enrichment threshold ( Fig. 1D ; Supplementary  Table S2 ). Effective ETV6 binding is expected to impact the expression of nearby genes. Accordingly, ETV6 peaks were associated to genes and compared to known ETV6-modulated genes (88 downregulated and 59 upregulated genes following ETV6-His expression in Reh cells) obtained by RNA-seq 32 . This strategy was performed through Distribution of the reads mapped to the CLIC5 gene after sequencing of the HA-immunoprecipitated DNA. A ChIP signal at the CLIC5A promoter region (arrow) is seen in all three ETV6-HA populations. (D) The number of ETV6 ChIP peak signals using variable peak fold enrichment thresholds (0.1 increments in a 3 to 7 range). The number of peaks drastically increases with peak fold enrichment thresholds <4. (E) Overlap percentage (left y axis) between the genes associated with putative ETV6 binding sites and known ETV6-modulated genes 32 (red line) or total ensembl genes (black line). The ratio between the percentages of overlap was calculated (blue line; right y axis) and increases with the stringency of the peak fold enrichment thresholds. (F) A Fisher's exact test p-value was calculated for the overlaps between ETV6 peaks and ETV6-modulated genes against the proportion of ETV6 peaks in the complete ensembl genes repertoire. The most significant enrichment is calculated at a peak fold enrichment of ≥4.5.
SCientiFiC RepoRtS | (2018) 8:15526 | DOI:10.1038/s41598-018-33947-1 the entire peak fold enrichment range ( Fig. 1E ; Supplementary Table S2 ). The overlap between ETV6 peaks and ETV6-modulated genes is systematically higher than the random probability given by the proportion of ETV6 peaks in the complete ensembl genes repertoire. The ratio calculated between these overlaps is directly correlated to the peak fold enrichment ( Fig. 1E , enrichment ratio; Supplementary Table S2 ), indicating that stronger ETV6 peaks are more likely associated with ETV6-mediated transcriptional regulation.
A peak fold enrichment ≥4.5 shows the strongest peak-to-gene expression association (Fisher's exact test p-value = 4.46E −35 ; Fig. 1F ; Supplementary Table S2 ). Using 4.5 as a specified threshold, 1,931 peaks were associated to 2,223 genes ( Supplementary Table S3 ), representing 3.6% of the total ensembl genes set (n = 60,235). However, 51 of the 147 (34.6%) known ETV6-modulated genes in Reh cells 32 have at least one associated peak called in this condition (74 expression-correlated peaks; Supplementary Table S4 ). By including expression data, we thus selected 1,931 high priority ETV6-bound regions that were used in the subsequent analyses.
ETV6 distribution across hematopoietic cell lines genomes. We next compared ETV6-bound regions identified in pre-B leukemia cells (Reh) to those of normal lymphoblastoid cells (GM12878) and myelogenous leukemia cells (K562) obtained from the ENCODE project ( Fig. 2A) . The overlap between Reh and GM12878 cells (368 of the 1,931 Reh peaks; 19.05%) was greater than with K562 cells (92 of the 1,931 Reh peaks; 4.76%), suggesting that the lineage (lymphoid vs. myeloid) is more likely to shape ETV6 binding compared to the differentiation stage (pre-B vs. B). The strongest overlap was however observed between K562 and GM12878 cells (988 of the 3,236 K562 peaks; 30.53%). Of note, the same antibody and immunoprecipitation protocol were used to generate these ENCODE datasets and might favor this overlap. Only 67 regions were bound by ETV6 in all 3 cell lines (3.47% of Reh peaks). Peaks shared across Reh and GM12878 cells were however not more associated to ETV6-modulated genes in Reh 32 ( Supplementary Table S5 ).
Genomic features of ETV6-bound regions. We next interrogated the genomic localization of ETV6
peaks. Figure 2B ("All peaks"; left panel) shows the percentage of peaks located within distinct genomic regions. The peaks are more often found (42%) within genes bodies (exons and introns). This distribution was similar in both GM12878 and K562 cells ( Supplementary Fig S2) . When we assessed the localization of expression-correlated ETV6 peaks, a stronger association (57%) was observed within gene ( Fig. 2B , right panel). ETV6 binding within genes seems to induce a change in gene expression.
The number of peaks located in the vicinity of the transcription start site (TSS) was assessed ( Fig. 2C ). Of the 1,931 ETV6 peaks, 502 (26%) were in the flanking region (+/− 10 kb) of a TSS. The highest number of peaks within this range is observed in the first 1,000 bp upstream of the TSS (Fig. 2C, left panel) . The distribution of ETV6 peaks observed in Reh cells is less TSS centered compared to GM12878 and K562 cells ( Supplementary  Fig S2) . Although the relatively small sample size of expression-correlated ETV6 peaks, they did not display a tighter distribution around the TSS. (Fig. 2C, right panel) , suggesting that ETV6-mediated transcription can be induced by distant TSS binding in Reh cells.
Epigenetic modifications in GM12878 cells were extensively investigated 41 compared to Reh. Considering the number of shared ETV6 peaks between Reh and GM12878 cell lines (368 peaks, Fig. 2A ), we assigned Reh-derived ETV6 peaks to specific chromatin states based on epigenetic data from the corresponding regions in GM12878 cells. Most of ETV6 peaks were associated to a quiescent state ( Fig. 2D, left panel) . However, when focusing on shared Reh and GM12878 ETV6 peaks, 45% of these were categorized as flanking active TSS (Fig. 2D , center panel; enriched for H3K4me3 and H3K4me1). Enhancers were also significantly enriched (Fig. 2D , center panel; enriched for H3K4me1 and high CpG methylation). In contrast, Reh-specific peaks are depleted for both flanking active TSS and enhancers chromatin states and are instead further associated with quiescent regions in GM12878 cells (Fig. 2D, right panel) , indicating that ETV6 binding to a given region appears to depend on a prerequisite chromatin environment.
Motifs enrichment of ETV6-bound regions. ETS transcription factors such as ETV6 have well-known binding motifs 24 . As expected, motif enrichment analyses revealed significant over-representation of ETS motifs within ETV6 peaks in Reh cells as well as in GM12878 and K562 cells (Fig. 3A,B ; Supplementary Table S6 ). Interestingly, based on the ranking of the enriched motifs, RUNX motifs were significantly more over-represented in Reh cells compared to GM12878 and K562 cells (Fig. 3A,B ; Supplementary Table S6 ). RUNX motifs are found centered on the peak summits similarly to ETS motifs ( Supplementary Fig S3) , indicating that RUNX-containing peaks are also properly bound. Unlike GM12878 and K562 cells, Reh cells express the ETV6-AML1 fusion protein that can interact with the bait protein ETV6-HA through their PNT domain and bind RUNX motifs 42 . Therefore, ETV6 ChIP-seq in this particular t(12;21)-positive background may have retrieved putative ETV6-AML1-bound regions in addition to ETV6-bound regions.
Only minor differences were observed when we assessed the global genomic localization pattern of ETV6 peaks according to the motif groups (refer to Fig. 3B ) in Reh cells (Fig. 3C ). However, ETV6 binding occurs predominantly in the first 1,000 bp upstream of TSS only in ETS-unique peaks (Fig. 3C ). With ETS motifs peaks being directly bound by ETV6-HA, the intensity (or peak fold enrichment) of these peaks is expected to be higher than RUNX motifs peaks which are presumably bound through ETV6-AML1. A striking difference is indeed observed when we compared the percentage of peaks containing only ETS (direct binding) or RUNX (indirect binding) motifs according to different peak fold enrichment (Fig. 3D ). ETS motifs become increasingly predominant among ETV6-bound regions with higher peak fold enrichment thresholds. Inversely, the fraction of ETV6-bound regions containing RUNX-unique motifs remains constant through the peak fold enrichment range.
ETV6 peaks containing ETS motifs (unique or with RUNX) are therefore significantly stronger (i.e. higher fold enrichment) than RUNX-unique peaks and ETS/RUNX depleted peaks (Fig. 3E) . Interestingly, peaks correlated with gene expression modulation have significantly higher fold enrichments ( Supplementary Table S7 ) without significant differences between motif groups ( Supplementary Fig S4) . We then assessed the relationship between motifs and expression. As shown in Fig. 3F , expression-correlated peaks are slightly more enriched for ETS motifs (unique or with RUNX) compared to all the peaks. Inversely, peaks lacking both ETS and RUNX motifs are less likely to induce a change in gene expression. All together, these data indicate that ETV6 predominantly binds ETS-containing sequences in vivo. ETS-driven binding of ETV6 is generally stronger than other binding events and are even more associated with a change in gene expression.
Although most ETV6 binding sites contain either ETS or RUNX motifs, a non-negligible fraction does not (38%, Fig. 3B ). Additional motif enrichment analyses revealed that only 10 motifs were significantly over-represented among this subset of ETS/RUNX free peaks (q-value < 0.1; Supplementary Table S8 ). IRF consensus sequences were present in 3 of these enriched motifs with one of them in conjunction with an ETS motif ( Supplementary Table S8 , see motif #4). Interestingly, this ETS-IRF compound motif was also strongly associated to expression regulation ( Supplementary Fig S5) . In fact, 10 of the 20 expression-correlated peaks lacking ETS or RUNX motifs instead contain this ETS-IRF compound motif. It is known that ETV6 can interact with IRF8 43 , suggesting a potential regulation through this interaction similarly to what was observed with RUNX motifs and ETV6-AML1. These results suggest a role for ETV6 as a cofactor at these loci.
Discussion
In this study, we provided the first in-depth mapping of ETV6 binding sites in t(12;21)-positive pre-B leukemia cells. We further associated ETV6 binding to transcriptional regulation by integrating expression data 32 . Despite the clear correlation between ETV6 binding and gene expression in the Reh cell line, ETV6 binding profile in these cells was markedly different of those obtained in other hematopoietic cell types. By including epigenetic data, we were able to unveil the importance of the cell type-specific chromatin environment on ETV6 binding. In this regard, roughly half of Reh-specific ETV6 peaks maps in quiescent regions of the lymphoblastoid cell line GM12878. The cell type-specific transcriptional programs and related active chromatin states thus modulate ETV6 binding. Although ubiquitously expressed, ETV6 impact on expression profiles might be different across tissues and cell types as its binding depends on higher order chromatin conformations. It is noteworthy that ETV6 silencing or overexpression in purified CD34 + cells from cord blood led to differentially expressed genes with however no recurrence with genes obtained in Reh cells (unpublished observations 32 ;), further demonstrating the cell-specific role of ETV6 in transcriptional regulation.
ETV6 binding might as well rely on other proteins 43, 44 whose availability would lead to additional complexity and divergences across cell types. For instance, ETV6-AML1 seems to shape ETV6 binding profile in Reh cells.
Although additional experiments could further strengthen our observations, the over-representation of RUNX motifs is likely a consequence of their interaction 42 as these sequences are expectedly targeted by the Runt domain of the fusion protein 29 . The contrasting distribution across TSS of ETV6 peaks in Reh cells compared to other cell types may be attributed to this interaction as the dissection per motif groups revealed a tighter distribution of ETS-unique peaks. Furthermore, not only ETV6 is recruited to RUNX-containing sequences but also induced changes in gene expression at these loci. RUNX-unique motifs were found in similar proportions within ETV6 peaks and expression-correlated peaks. More importantly, ETV6 peaks containing both ETS and RUNX consensus binding sequences were even more associated with differentially expressed genes. These regions may be bound synergistically by the complex formed by ETV6-HA and endogenous ETV6-AML1 through their ETS and Runt domains, respectively. Interestingly, the expression of ETV6 32 or the knock-down of ETV6-AML1 31 in Reh cells lead to common differentially expressed genes (37 of the 147 ETV6-modulated genes are also differentially expressed upon ETV6-AML1 knock-down), further suggesting that ETV6 and ETV6-AML1 cooperate in transcriptional regulation. Additionally, it remains possible that a fraction of RUNX-containing peaks could have been retrieved through the recruitment of ETV6 to AML1 itself as several reports described an interaction between AML1 and other ETS transcription factors [45] [46] [47] [48] .
In addition to its canonical function to directly bind ETS sequences, ETV6 seems to be recruited to additional sites, indicating that ETV6 can act as a cofactor without direct DNA-binding. The most striking example is the high occurrence of RUNX motifs that could be explained by the ETV6-AML1 fusion protein in Reh cells. However this is unique to the specific t(12;21)-positive background of these cells and might not reflect the general impact of ETV6 in normal cells. Nonetheless, a significant proportion of peaks contained neither ETS nor RUNX motifs but were still associated to a change in gene expression. These peaks were enriched for IRF binding sites in combination or not with ETS sites. This result is supported by the known interaction between ETV6 and IRF8 43 and further suggests that the interaction between ETV6 (and potentially other ETS factors) and IRF proteins is a rather common mechanism of transcriptional regulation. The function of ETV6 as a cofactor is however poorly understood and additional efforts are required to uncover putative partners and characterize their functions.
All together, this report indicates that ETV6 binding is highly flexible and therefore ETV6 inactivation is expected to induce unique transcriptional modifications in a given cellular context. The wide spectrum of hematological diseases associated with ETV6 alterations 5-10 could be explained, at least partially, by the distinct ETV6 regulatory network of the cell originally affected by the mutation. Accordingly, the complete disruption of ETV6 observed in most t(12;21)-positive childhood pre-B ALL cases 17-21 may induce specific transcriptional changes required for complete leukemic transformation. Although this study dissected ETV6 binding and clarified its transcriptional network in t(12;21)-positive pre-B leukemia cells 32 , it remains challenging to associate ETV6 target genes to leukemia-related phenotypes as their functions are, for most of them, still unclear.
Conclusions
Molecular characterization of ETV6 function is mandatory to fully understand its role in leukemogenesis. Towards this goal we built the first genome wide map of ETV6 binding sites in pre-B leukemia cells bearing the recurrent t(12;21) translocation. By including expression data, we obtained the detailed transcriptional network of ETV6 in these cells. This comprehensive analysis exposed the binding properties of ETV6 and suggests that ETV6 could also act as a cofactor to regulate gene expression. With the recent reports connecting germline ETV6 mutations to a panel of familial hematological diseases and given the complexity of ETV6-mediated transcription, further characterization of ETV6 remains valuable.
